Mark Fisher

Mark Fisher is a seasoned clinical development professional with over 25 years of experience in clinical operations, currently serving as Vice President of Clinical Operations at Sutro Biopharma, Inc. since November 2024. Fisher held previous leadership roles including Senior Vice President at Blue Lake Biotechnology and President of Mark Fisher Consultants, where expertise in global clinical strategies and cross-functional integration was demonstrated. Notable positions also include Head of Hematology Oncology Clinical Operations at AstraZeneca and Vice President-Head of Clinical Science at Acerta Pharma B.V. Fisher possesses a strong track record in managing all phases of clinical trials, regulatory assessments, and strategic collaborations, with a specific focus on oncology and immuno-oncology. Educational credentials include a Bachelor of Science in Molecular Biology from San Francisco State University.